Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells

Justin Wray, Elizabeth A. Williamson, Melanie Royce et al. · 2009

Read Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells by Justin Wray, Elizabeth A. Williamson, Melanie Royce et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005323.txt.

Description

When DNA replicates, the two new strands come out tangled and must be unlinked before division. The enzyme topoisomerase II alpha does that unlinking, and drugs that block it are common cancer treatments. Wray and colleagues found a resistance factor in breast cancer cells in PLOS ONE in 2009.

Cells watch their tangling status and can trigger checkpoints when unlinking lags. The protein Metnase mediates resistance to topoisomerase II inhibitors, as the title states. Knowing the resistance factor gives drug designers a second target to restore the power of these widely used drugs.

Catalog record

CREATORJustin Wray, Elizabeth A. Williamson, Melanie Royce et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005323

Browse the full library · About the Tower of Babel